1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Investigational aQIVc: new trials by email Literature Review of Investigational aQIVc trials Research Report on Investigational aQIVc
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older Investigational aQIVc, licensed QIVr, licensed aQIV - Influenza, Human | Phase 3 | Completed | Seqirus | 7741 | 2023-11-03 | 2025-04-27 |
Influenza, Human (1)
Seqirus (1)
Canada (1) · Denmark (1) · Estonia (1) · Germany (1) · Pakistan (1) · Philippines (1) · United Kingdom (1) · United States (1)